◓ FOOD & AGRICULTURE 3 YEARS HORIZON RESOLVES 1 NOV 2029 · in 3.0y

Cultivated meat achieves widespread retail supermarket availability in the United States before 2028.

While FDA and USDA have cleared select lab-grown poultry for restricted restaurant sales, high production costs limit retail distribution. Resolution requires consumer purchase in major US grocery chains.

Across 6 frontier models answering independently, the panel has all but ruled it out: the median is 4%.

They broadly agree, 14 points between GPT at 18% and Gemini at 4%.

Nothing is settled until 1 Nov 2029, when the outcome is checked against sources and every number above gets a permanent score.

MODEL BY MODEL

What each one said

  • GPTOpenAI

    This hinges on USDA approvals and whether producers can cut costs enough for national chains to stock repeat-purchase products.

    • FDA/USDA cleared UPSIDE and GOOD Meat chicken in 2023, but neither has established broad U.S. grocery distribution.
    • Before 2028, producers need inspected scale-up, reliable supply, viable pricing, and deals with chains such as Kroger or Walmart.
    • I would raise this sharply if a major chain announced multi-state listings with sustained weekly supply by 2027.
    openai/gpt-5.6-terra · asked 2 Nov 2026
    18%
  • GrokxAI

    Retail scale by end-2027 hinges on bioreactor costs collapsing enough for supermarket SKUs.

    • USDA/FDA poultry clearance already exists for restaurants; retail needs 10-100x cheaper production and chain contracts by Dec 2027.
    • Plant-based meats took 4-6 years from first sales to major-chain ubiquity; cultivated meat’s capex and media costs sit far above that base.
    • A 2027 cost-breakthrough announcement from Upside/GOOD Meat plus a Kroger/Walmart pilot would most shift the odds.
    x-ai/grok-4.6 · asked 2 Nov 2026
    12%
  • GeminiGoogle

    Bioreactor scaling economics and state-level legislative bans prevent supermarket-level distribution within two years.

    • Scaling to retail volume requires megawatt-scale bioreactor capacity that neither Upside Foods nor GOOD Meat has funded or built.
    • Florida and Alabama already enacted retail bans in 2024, creating legal fragmentation that deters nationwide grocery chains.
    • A massive bioreactor Capex breakthrough by early 2027 would raise odds, but commercial construction timelines exceed 18 months.
    google/gemini-3.8-flash · asked 2 Nov 2026
    4%
  • ClaudeAnthropic

    Hinges on production cost collapse to retail-viable price points, which no company has demonstrated at scale.

    • Current cultivated meat production costs remain 10-100x conventional meat with no commercial-scale bioreactors proven by 2026.
    • Only Upside Foods and GOOD Meat have USDA clearance and both sell exclusively through a handful of restaurants, not retail.
    • Several states (Florida, Alabama, others) have banned cultivated meat sales outright, further narrowing any path to 'widespread' US retail by 2029.
    anthropic/claude-sonnet-5 · asked 2 Nov 2026
    4%
  • DeepSeekDeepSeek

    Turns on cost per pound falling below conventional chicken, which no producer is close to.

    • Upside Foods and Good Meat cleared FDA/USDA in 2023 but still sell only via a handful of high-end restaurants at premium prices.
    • Retail requires ~$5-10/lb at scale; current cultivated chicken runs orders of magnitude above that, with no commercial-scale plant operating in the US.
    • The 2029 deadline gives ~3 years, but no producer has announced a retail launch date or a facility capable of grocery volumes.
    deepseek/deepseek-v4.1-flash · asked 2 Nov 2026
    4%
  • QwenAlibaba

    Production cost per pound must drop an order of magnitude and major chains must stock it—all within ~14 months.

    • No cultivated meat company has demonstrated retail-scale production; Upside and Good Meat remain at restaurant-limited volumes with costs still 5-10x conventional…
    • Major grocery chains (Kroger, Walmart) require 12-18 month lead times for new category onboarding even after a product is ready, eating most of the remaining window.
    • Every prior industry timeline for retail availability has slipped by 2+ years; a breakthrough bioreactor or scaffold cost collapse would be needed to change this.
    qwen/qwen3.8-max-0902 · asked 2 Nov 2026
    4%

6 of 6 models answered · 14 points between the highest and lowest. None was shown the market price.

WHAT DO YOU THINK?
loading…

Question sourced from a news sweep on 2 Nov 2026. Forecast by google/gemini-3.8-flash, anthropic/claude-sonnet-5, openai/gpt-5.6-terra, x-ai/grok-4.6, deepseek/deepseek-v4.1-flash, qwen/qwen3.8-max-0902 via OpenRouter.